ZA95463B - Use of interleukin-12 to prevent graft-versus-host disease - Google Patents

Use of interleukin-12 to prevent graft-versus-host disease

Info

Publication number
ZA95463B
ZA95463B ZA95463A ZA95463A ZA95463B ZA 95463 B ZA95463 B ZA 95463B ZA 95463 A ZA95463 A ZA 95463A ZA 95463 A ZA95463 A ZA 95463A ZA 95463 B ZA95463 B ZA 95463B
Authority
ZA
South Africa
Prior art keywords
interleukin
versus
host disease
prevent graft
prevent
Prior art date
Application number
ZA95463A
Other languages
English (en)
Inventor
Megan Sykes
Stanley F Wolf
Original Assignee
Genetics Inst
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, Gen Hospital Corp filed Critical Genetics Inst
Publication of ZA95463B publication Critical patent/ZA95463B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA95463A 1994-01-21 1995-01-20 Use of interleukin-12 to prevent graft-versus-host disease ZA95463B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/186,529 US5573764A (en) 1994-01-21 1994-01-21 Use of interleukin-12 to prevent graft versus host disease

Publications (1)

Publication Number Publication Date
ZA95463B true ZA95463B (en) 1995-09-27

Family

ID=22685309

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA95463A ZA95463B (en) 1994-01-21 1995-01-20 Use of interleukin-12 to prevent graft-versus-host disease

Country Status (14)

Country Link
US (2) US5573764A (de)
EP (1) EP0739212B1 (de)
JP (1) JP3825043B2 (de)
AT (1) ATE215380T1 (de)
AU (1) AU698410B2 (de)
CA (1) CA2181568C (de)
DE (1) DE69526206T2 (de)
DK (1) DK0739212T3 (de)
ES (1) ES2179096T3 (de)
IL (1) IL112373A (de)
PT (1) PT739212E (de)
TW (1) TW349021B (de)
WO (1) WO1995019786A1 (de)
ZA (1) ZA95463B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
JP2000510813A (ja) * 1995-02-06 2000-08-22 ジェネテイックス・インスティテュート・インコーポレイテッド Ｉｌ−１２用処方
WO1997016203A1 (en) * 1995-11-01 1997-05-09 Genetics Institute, Inc. Methods for administration of il-12
CA2268365A1 (en) * 1996-10-18 1998-04-30 Jeff Nordstrom Il-12 gene expression and delivery systems and uses
EP0931156A2 (de) * 1996-10-18 1999-07-28 Valentis Inc. Genexpressions- und transfersysteme und deren verwendungen
AU6150498A (en) * 1997-02-07 1998-08-26 Wistar Institute, The Methods and compositions for the inhibition of interleukin-12 production
EP0919241B1 (de) * 1997-05-16 2004-08-04 Toray Industries, Inc. Medikament, behandlungsmethode, prophylaktikum und prophylaxe gegen immunologische erkrankungen von hunden und katzen
EP1516630A3 (de) * 1997-10-31 2006-05-03 Wyeth Verwendung von anti-il-12 Antikörpern bei Transplantationsabstossungen
US6080399A (en) * 1998-04-23 2000-06-27 Arch Development Corporation Vaccine adjuvants for immunotherapy of melanoma
US7115712B1 (en) * 1999-12-02 2006-10-03 Maxygen, Inc. Cytokine polypeptides
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US7718196B2 (en) * 2001-07-02 2010-05-18 The United States Of America, As Represented By The Department Of Health And Human Services Rapamycin-resistant T cells and therapeutic uses thereof
US20040241153A1 (en) * 2001-08-31 2004-12-02 Fowler Daniel H. Methods of generating human cd4+ th1 cells
US20040258661A1 (en) * 2001-10-31 2004-12-23 Daniel Fowler Generation of use of tc1 and tc2 cells
WO2003004625A1 (en) * 2001-07-02 2003-01-16 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Methods of generating human cd4+ th2 cells and uses thereof
DE10248141B4 (de) * 2002-10-11 2007-04-19 Universitätsklinikum Hamburg-Eppendorf Nukleinsäuren und deren Verwendung für die Gentherapie
US7939058B2 (en) 2003-07-03 2011-05-10 University Of Southern California Uses of IL-12 in hematopoiesis
WO2009048560A1 (en) * 2007-10-08 2009-04-16 Intrexon Corporation Engineered dendritic cells and uses for the treatment of cancer
US20100272863A1 (en) * 2009-04-24 2010-10-28 Griebel Jonathan M Soft shaped tortillas
JP6267510B2 (ja) 2010-05-18 2018-01-24 ニューメディシンズ，インコーポレーテッド 造血を増強するためのｉｌ−１２製剤
CA2839261A1 (en) 2011-06-13 2012-12-20 Neumedicines, Inc. Mitigation of cutaneous injury with il-12
WO2013016634A1 (en) 2011-07-27 2013-01-31 Neumedicines, Inc. Use of il-12 to generate endogenous erythropoietin
EP2766035B1 (de) * 2011-10-11 2018-03-28 Universität Zürich Prorektorat MNW Kombinationsmedikament mit il-12 und einem mittel zur blockade von t-zellen-hemmer-molekülen zur tumortherapie
US11951157B2 (en) 2011-10-11 2024-04-09 Universitat Zurich Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody
US9636381B2 (en) 2012-01-18 2017-05-02 Neumedicines, Inc. Methods for radiation protection by administering IL-12
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
MX2022012823A (es) * 2020-04-17 2023-01-04 Univ Leland Stanford Junior Polipéptidos modificados de il-12 e il-23 y usos de los mismos.
US20220162638A1 (en) * 2020-10-13 2022-05-26 Kriya Therapeutics, Inc. Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA931489B (en) * 1992-03-04 1993-10-28 Schering Corp Use of interleuken-10 to suppress graft-vs-host disease
DE4315127A1 (de) * 1993-05-07 1994-11-10 Behringwerke Ag Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease

Also Published As

Publication number Publication date
PT739212E (pt) 2002-08-30
IL112373A0 (en) 1995-03-30
CA2181568A1 (en) 1995-07-27
JPH09508371A (ja) 1997-08-26
US5573764A (en) 1996-11-12
AU698410B2 (en) 1998-10-29
IL112373A (en) 2006-08-01
WO1995019786A1 (en) 1995-07-27
TW349021B (en) 1999-01-01
ATE215380T1 (de) 2002-04-15
DE69526206D1 (de) 2002-05-08
EP0739212B1 (de) 2002-04-03
ES2179096T3 (es) 2003-01-16
CA2181568C (en) 2007-09-18
JP3825043B2 (ja) 2006-09-20
EP0739212A1 (de) 1996-10-30
AU1687595A (en) 1995-08-08
DE69526206T2 (de) 2002-11-21
DK0739212T3 (da) 2002-06-03
US5756085A (en) 1998-05-26

Similar Documents

Publication Publication Date Title
ZA95463B (en) Use of interleukin-12 to prevent graft-versus-host disease
SG49658A1 (en) Treatment of condition and disease
HK1015280A1 (en) Use of epinastine in the treatment of pain
EP0441119A3 (en) The use of l-arginine in the treatment of hypertension and other vascular disorders
EP0954303A4 (de) Verfahren zur behandlung von mentalkrankheiten, entzündungen und schmerz
UA32429C2 (uk) Засіб для лікування нетримання сечі
GB9320747D0 (en) A compress for use in the cold and/or hot treatment of an injury
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
EP0651639A4 (de) Verfahren zur verwendung von (+)-cisaprid zur behandlung der reflux-ösophagitis und anderer erkrankungen.
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
ZA935575B (en) Therapeutic agent and its use.
NO913054D0 (no) Vaginal behandlingsprosess og innretning med dusj.
EP0833641A4 (de) Behandlung und vorbeugung von erkrankungen der prostata
EP0745597A3 (de) Melatonergische Indanylpiperazine oder Homopiperazine
ZA977004B (en) Therapeutic product and its use
GB2230443B (en) Treatment of sleep apnoea
张钦 et al. EJACULATIO DEFICIENS TREATED WITH ACUPUNCTURE REPORT OF 110 CASES
ES2159479A1 (es) Nuevos indazoles como inhibidores de la ciclooxigenasa-ii
ZA963998B (en) 3,4-Disubstituted-phenylsulphonamides and their therapeutic use
ZA963999B (en) 3,4-Disubstituted-phenylsulphonamides and their therapeutic use
EG19049A (en) Solid thiocarbonates and methods of manufacture and use.
GB9312780D0 (en) Therapeutic and cosmetic treatment
GEP19971009B (en) Flupirtine in combination with antiparkinsonica against muscle bracing
GR900200303U (en) Face and body skin treatment
SI0804182T1 (en) Use of gabapentin in the treatment of anxiety and panic